Related Experiment Video
Updated: Mar 18, 2026
05:51
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
26.6K
Proteome-wide Mendelian randomization and colocalization analyses identify potential biomarkers for schizophrenia
Jingyu Lin1, Haiming Huang2, Lin Chen1
1Beijing Huilongguan Hospital, Capital Medical University, Beijing, China.
Frontiers in Psychiatry
|March 16, 2026
Summary
This study used Mendelian randomization to identify seven plasma proteins causally linked to schizophrenia (SCZ) risk. These findings highlight potential new targets for schizophrenia treatment and mechanistic research.
Area of Science:
- Genetics
- Proteomics
- Psychiatric Disorders
Background:
- Schizophrenia (SCZ) is a complex psychiatric disorder with a significant genetic component.
- Understanding the biological pathways underlying SCZ is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the causal relationships between plasma protein levels and schizophrenia risk.
- To identify specific proteins that may play a role in SCZ pathogenesis.
Main Methods:
- Proteome-wide Mendelian randomization (MR) analysis using genetic instruments for 4,907 plasma proteins.
- Summary statistics for SCZ from the Psychiatric Genomics Consortium (PGC).
- External validation using cis-pQTLs from the Fenland study and UK Biobank Pharma Proteomics Project (UKB-PPP), and brain cis-eQTLs from GTEx. Bayesian colocalization was employed to assess shared causal variants.
Main Results:
- Seven plasma proteins showed significant associations with SCZ risk: ADAM22, LIMA1, CTSS, FOXO3, IRF3, KLC1, and MMP16.
- Associations for LIMA1, CTSS, FOXO3, KLC1, and MMP16 were partially replicated in external datasets.
- Bayesian colocalization strongly supported shared causal variants for FOXO3, IRF3, and LIMA1 with SCZ.
- CTSS, FOXO3, IRF3, and MMP16 demonstrated interactions with known antipsychotic drug targets.
Conclusions:
- This study provides robust evidence for the causal roles of specific plasma proteins in SCZ.
- Identified proteins represent promising candidates for further mechanistic studies and therapeutic development in schizophrenia.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
16.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.5K
01:29Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73